Cargando…
Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
With increasing numbers of vaccine-breakthrough infections worldwide, assessing the immunogenicity of vaccinated health-care workers that are frequently exposed to SARS-CoV-2-infected individuals is important. In this study, neutralization titers against SARS-CoV-2 were assessed one month after comp...
Autores principales: | Sølund, Christina, Underwood, Alexander P., Fernandez-Antunez, Carlota, Bollerup, Signe, Mikkelsen, Lotte S., Villadsen, Signe Lysemose, Fahnøe, Ulrik, Winckelmann, Anni Assing, Feng, Shan, Nørløv Vinten, Caroline A., Dalegaard, Magnus Illum, Vizgirda, Greta, Sørensen, Anna-Louise, Ramirez, Santseharay, Bukh, Jens, Weis, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780959/ https://www.ncbi.nlm.nih.gov/pubmed/35062736 http://dx.doi.org/10.3390/vaccines10010075 |
Ejemplares similares
-
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
por: Underwood, Alexander P., et al.
Publicado: (2023) -
Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
por: Underwood, Alexander P., et al.
Publicado: (2021) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022) -
mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023) -
mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)